Address

Oxford Bioscience Partners
222 Berkeley Street
Suite 1650
Boston, MA 02116
United States

Open map


Recent investment activity

KANDO id: 29931

Corporate information

Founders
Also known as
OBP
Registration country

Funds managed

Fund Type Vintage Currency Committed capital
Oxford Bioscience Annex Fund Venture 2002 USD 20,200,000
Oxford Bioscience Partners IV LP Venture 2001 USD 454,500,000
Oxford Bioscience Partners III LP Venture 1999 USD 236,000,000
Oxford Bioscience Partners II LP Venture 1997 USD 107,000,000

Funding rounds

Profile Country
Chevron Technology Ventures LLC (CTV) Corporate venturing subsidiary of ChevronTexaco, focusing on the commercialisation and integration of emerging technologies within Chevron

Top investment portfolio themes
medtech (1)  

Actual initial investment stage
Venture (1)

Investment activity status
Active investor

Selected investments

Displaying 1 - 25 of 37
Profile Country Date Funding
CGI Pharmaceuticals Inc A biopharmaceutical company developing small molecule therapeutics for multiple oncology and immunology-based indications. N/A
Claros Diagnostics Inc point-of-care medical diagnostic company Series B
Claros Diagnostics Inc point-of-care medical diagnostic company Series A
Coherex Medical Inc Development of devices that address structural heart disease. N/A
Concentric Medical Inc N/A
Corixa Corp N/A
Dicerna Pharmaceuticals Inc N/A
Dicerna Pharmaceuticals Inc N/A
Dynogen Pharmaceuticals Inc Drug company focused on gastrointestinal and genitourinary disorders. N/A
Glori Energy Inc N/A
HydroCision Inc HydroCision is the leading developer, manufacturer, and marketer of fluidjet based surgical tools for the spine market. Series G
ImpactRX Inc N/A
Inverness Medical Innovations Inc Cholesteral testing device N/A
Luca Technologies Inc N/A
Memory Pharmaceuticals Corp N/A
MicroMed Technology Developer of miniaturized heart pump technology. Series D
nFocus Neuromedical Inc Innovative next generation neurovascular devices. N/A
Pathway Medical Technologies Inc Manufacturer of medical devices for the treatment of arterial disease. Series D
Pathway Medical Technologies Inc Manufacturer of medical devices for the treatment of arterial disease. Series C
Scion Pharmaceuticals Inc N/A
SmartPill Corp Developer and manufacturer of ingestible, capsule-based medical devices. N/A
Stratagene Corp N/A
Tragara Pharmaceuticals Inc Development of proprietary drugs for the treatment of cancer and inflammation-related disorders. N/A
Trubion Pharmaceuticals Inc N/A
VaxInnate Inc A biotechnology company, engages in the development and production of vaccines for pandemic and seasonal influenza diseases. Series C

Past employees

Selected Products / Customers

Financials